Prevention of Preterm Labour: 2011 Update on Tocolysis
The aim of this paper is to review available data about drugs for preventing preterm labour. Tocolytic therapy includes β adrenergic receptor agonists, NO donors, magnesium sulphate, prostaglandin-synthase inhibitors, oxytocin receptor antagonists, calcium-channel blockers, progesterone, 17-α-hydrox...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Journal of Pregnancy |
| Online Access: | http://dx.doi.org/10.1155/2011/941057 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832554318488666112 |
|---|---|
| author | C. Hubinont F. Debieve |
| author_facet | C. Hubinont F. Debieve |
| author_sort | C. Hubinont |
| collection | DOAJ |
| description | The aim of this paper is to review available data about drugs for preventing preterm labour. Tocolytic therapy includes β adrenergic receptor agonists, NO donors, magnesium sulphate, prostaglandin-synthase inhibitors, oxytocin receptor antagonists, calcium-channel blockers, progesterone, 17-α-hydroxyprogesterone caproate, and antibiotics. Their specific effects on myometrial contractility, their safety, their efficiency, and side effects profile for the mother and the fetus are presented. The main question of why and for what reasons tocolysis should be administrated is discussed. |
| format | Article |
| id | doaj-art-d02541915d1647579f1130f3865c073e |
| institution | Kabale University |
| issn | 2090-2727 2090-2735 |
| language | English |
| publishDate | 2011-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Pregnancy |
| spelling | doaj-art-d02541915d1647579f1130f3865c073e2025-02-03T05:51:55ZengWileyJournal of Pregnancy2090-27272090-27352011-01-01201110.1155/2011/941057941057Prevention of Preterm Labour: 2011 Update on TocolysisC. Hubinont0F. Debieve1Department of Obstetrics, Saint-Luc University Hospital, 10 Avenue Hippocrate, 1200 Bruxelles, BelgiumDepartment of Obstetrics, Saint-Luc University Hospital, 10 Avenue Hippocrate, 1200 Bruxelles, BelgiumThe aim of this paper is to review available data about drugs for preventing preterm labour. Tocolytic therapy includes β adrenergic receptor agonists, NO donors, magnesium sulphate, prostaglandin-synthase inhibitors, oxytocin receptor antagonists, calcium-channel blockers, progesterone, 17-α-hydroxyprogesterone caproate, and antibiotics. Their specific effects on myometrial contractility, their safety, their efficiency, and side effects profile for the mother and the fetus are presented. The main question of why and for what reasons tocolysis should be administrated is discussed.http://dx.doi.org/10.1155/2011/941057 |
| spellingShingle | C. Hubinont F. Debieve Prevention of Preterm Labour: 2011 Update on Tocolysis Journal of Pregnancy |
| title | Prevention of Preterm Labour: 2011 Update on Tocolysis |
| title_full | Prevention of Preterm Labour: 2011 Update on Tocolysis |
| title_fullStr | Prevention of Preterm Labour: 2011 Update on Tocolysis |
| title_full_unstemmed | Prevention of Preterm Labour: 2011 Update on Tocolysis |
| title_short | Prevention of Preterm Labour: 2011 Update on Tocolysis |
| title_sort | prevention of preterm labour 2011 update on tocolysis |
| url | http://dx.doi.org/10.1155/2011/941057 |
| work_keys_str_mv | AT chubinont preventionofpretermlabour2011updateontocolysis AT fdebieve preventionofpretermlabour2011updateontocolysis |